✦ LIBER ✦

Use of recombinant factor Vlla (rFVlla) in liver transportation

✍ Scribed by Raymond M. Planinsic

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 46 KB
Volume: 12
Category: Article
ISSN: 1527-6465
DOI: 10.1002/lt.20750

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Use of recombinant factor VIIa during or

Use of recombinant factor VIIa during orthotopic liver transplantation

✍ Andrea De Gasperi; Francesco Baudo 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 46 KB

The role of recombinant factor VIIa in l

The role of recombinant factor VIIa in liver transplantation

✍ Robert J. Porte; Stephen H. Caldwell 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB 👁 1 views

Efficacy and safety of repeated perioper

Efficacy and safety of repeated perioperative doses of recombinant factor VIIa in liver transplantation

✍ J. Peter A. Lodge; Sven Jonas; Robert M. Jones; Michael Olausson; José Mir-Palla 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 144 KB 👁 1 views

## Patients undergoing orthotopic liver transplantation (OLT) have excessive blood loss during surgery that requires blood transfusions, leading to increased postoperative morbidity and mortality. We studied the efficacy and safety of activated recombinant factor VII (rFVIIa) in reducing transfusio

Safety and efficacy of a single bolus ad

Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease

✍ Raymond M. Planinsic; Jan van der Meer; Giuliano Testa; Luis Grande; Angel Cande 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 131 KB 👁 1 views

Orthotopic liver transplantation (OLT) can be associated with excessive blood loss. As a result, there may be increased risk of adverse outcomes. Activated recombinant factor VII (rFVIIa) has demonstrated the ability to improve hemostasis in a variety of disorders; however, there has been a limited

Regional biologic therapy. Hepatic arter

Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastases

✍ Giora M. Mavligit; Alexander A. Zukixvski; Chuslip Charnsangavej; C. Humberto Ca 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Suppression of metastasis of human pancr

Suppression of metastasis of human pancreatic cancer to the liver by transportal injection of recombinant adenoviral NK4 in nude mice

✍ Mitsuhiko Murakami; Eishi Nagai; Kazuhiro Mizumoto; Michiyo Saimura; Kenoki Ohuc 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 396 KB 👁 1 views

NK4, a 4-kringle fragment of hepatocyte growth factor (HGF), is an HGF antagonist that also acts as an angiogenesis inhibitor. NK4 strongly inhibits the infiltration, metastasis, and tumor growth of pancreatic cancer. The aim of our study was to evaluate the antitumor effect of adenovirus-mediated N